Annie Gauthier

Annie Gauthier is a partner in BCF’s Business Law group and heads the firm’s Life Sciences team. She focuses her practice on mergers and acquisitions, private equity, venture capital, and corporate and transactional law. She regularly represents private companies, investment funds, and private equity firms in connection with their growth, acquisition, and financing strategies. Recognized as one of Québec’s most respected lawyers in the life sciences sector, she has extensive knowledge of the pharmaceutical, biotechnology, and medical technology industries.

With more than 20 years of experience, Annie has practised at leading national and international law firms. She acts as a trusted advisor to entrepreneurs, founders, executives, and investors, guiding organizations through every stage of their development, from emerging companies to well-established businesses. She also advises private equity funds and institutional investors on their equity investments, strategic acquisitions, and the development of their portfolio companies. Over the years, she has been involved in numerous domestic and cross-border transactions of all sizes across a wide range of industries.

In recent years, Annie has also developed a strong strategic governance practice. She works closely with management teams, boards of directors, and life sciences investors on growth, financing, restructuring, and value-creation initiatives. She also serves as corporate secretary to numerous SMEs and growing companies, advising directors and executives on implementing effective governance practices tailored to their stage of development and investor expectations.

Deeply engaged in Québec’s life sciences ecosystem, Annie served on the IRICoR board of directors from 2016 to 2026, a pan-Canadian centre of excellence dedicated to accelerating the discovery, development, and commercialization of innovative drugs arising from academic research. More recently, she joined the Board of Governance of the Université de Montréal’s Institute for Research in Immunology and Cancer (IRIC), one of Canada’s leading biomedical research centres. Her long-standing involvement with these organizations reflects her conviction that building a high-performing innovation ecosystem requires close collaboration among the research community, entrepreneurs, investors, and industry partners.

Before joining BCF, Annie served as Director, Transactions at Pharmascience, one of the largest employers in Québec’s pharmaceutical industry. Her experience with this major international pharmaceutical company gave her first-hand insight into the industry’s commercial, regulatory, and strategic challenges and enabled her to participate in transactions across several continents. This experience at the intersection of law and business now allows her to provide clients with practical and strategic advice focused on achieving their business objectives.